Article Text
Pancreatobiliary
Review
Recent advances in the diagnosis and management of pancreatic neuroendocrine tumours
Abstract
The incidence of pancreatic neuroendocrine tumours (PNET) is rising mainly due to the increased use of cross-sectional imaging. Although many PNETs are asymptomatic and non-functioning, the overall 5-year survival is still less than 50%. In this article, we review the advances in diagnosis, classification and staging of PNET that have evolved with the development of new cross-sectional imaging methods and biopsy techniques. With accurate classification, evidence-based, individualised prognostic outcomes and treatments are able to be given which are also discussed.
- pancreatic cancer
- pancreatic disorders
- pancreatic tumours
- pancreatic islet cell
- pancreatic endocrine tumour